A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Takeda
Takeda
VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Tempus AI
Incyte Corporation
Actym Therapeutics, Inc.
Elevation Oncology
Novartis
Tango Therapeutics, Inc.
NantCell, Inc.
Pfizer
ADC Therapeutics S.A.
Ikena Oncology
OHSU Knight Cancer Institute
pharmaand GmbH
Fate Therapeutics
Hoffmann-La Roche
Genmab
MacroGenics
National Institutes of Health Clinical Center (CC)
Lumos Pharma
Cambridge University Hospitals NHS Foundation Trust
Tocagen Inc.
National Institutes of Health Clinical Center (CC)
CureOne
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Washington University School of Medicine
sigma-tau i.f.r. S.p.A.
Mayo Clinic
Western Regional Medical Center
Incyte Corporation
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI)
Calando Pharmaceuticals
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Cancer Research UK
Mayo Clinic
Millennium Pharmaceuticals, Inc.